Maverick Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-13,528
Closed -$1.7M 512
2021
Q3
$1.7M Sell
13,528
-7,787
-37% -$1.01M 0.02% 200
2021
Q2
$2.65M Buy
21,315
+6,067
+40% +$762K 0.02% 140
2021
Q1
$1.8M Sell
15,248
-568
-4% -$66.6K 0.02% 161
2020
Q4
$1.85M Buy
+15,816
New +$1.74M 0.03% 141
2019
Q1
Sell
-44,470
Closed -$4.04M 308
2018
Q4
$4.04M Buy
+44,470
New +$4.16M 0.06% 205

Other funds holding MDT

Maverick Capital's MDT Position: Q4 2021 in Review

Maverick Capital sold out of Medtronic (MDT) in Q4 2021, closing a stake of 13,528 shares — an estimated $1.7M sold.

Maverick Capital first reported a position in MDT in Q4 2018 and held it in 5 quarters. The position peaked at $4.04M in Q4 2018. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Maverick Capital reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • Maverick Capital sold 13,528 Medtronic shares in Q4 2021, an estimated $1.7M.
  • Maverick Capital first reported a position in Medtronic in Q4 2018 and held it in 5 quarters.
  • Maverick Capital's Medtronic position peaked at $4.04M in Q4 2018.
  • 2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Maverick Capital's 13F filing for Q4 2021, filed 14 Feb 2022.